Description of new cytochrome P450 2D6 (CYP2D6) alleles resulting from aberrant crossover between CYP2136 and CYP2D7

被引：0
|
作者：
Kramer, Whitney E.
Dukek, Brian A.
Bruflat, Jamie K.
Walker, Denise A.
O'Kane, Dennis J.
Mrazek, David A.
Black, John Logan
机构：
[1] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MN USA
[2] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA
[3] Mayo Clin, Coll Med, Dept Psychiat, Psychol Psychogenom Lab, Rochester, MN USA
来源：
BIOLOGICAL PSYCHIATRY | 2007年 / 61卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
408
引用
收藏
页码：126S / 126S
页数：1
相关论文
共 50 条
  • [41] IN VITRO COMPARATIVE INHIBITORY PROFILES OF SEVERAL CYP2D6 INHIBITORS AND METABOLIC CAPABILITIES OF CYP2D6*1, CYP2D6*2, CYP2D6*10, AND CYP2D6*17 ON TRAMADOL METABOLISM
    Nahid, N.
    Kanumuri, S.
    Sharma, A.
    Wang, D.
    Johnson, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S74 - S75
  • [42] Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity
    Dalton, Rachel
    Lee, Seung-been
    Claw, Katrina G.
    Prasad, Bhagwat
    Phillips, Brian R.
    Shen, Danny D.
    Wong, Lai Hong
    Fade, Mitch
    McDonald, Matthew G.
    Dunham, Maitreya J.
    Fowler, Douglas M.
    Rettie, Allan E.
    Schuetz, Erin
    Thornton, Timothy A.
    Nickerson, Deborah A.
    Gaedigk, Andrea
    Thummel, Kenneth E.
    Woodahl, Erica L.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (01): : 147 - 156
  • [43] CYP2D6 polymorphism in a Gabonese population:: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype
    Panserat, S
    Sica, L
    Gérard, N
    Mathieu, H
    Jacqz-Aigrain, E
    Krishnamoorthy, R
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (01) : 121 - 124
  • [44] Effect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizers
    Madani, S
    Barilla, D
    Cramer, J
    Wang, YB
    Paul, C
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11): : 1211 - 1218
  • [45] ASSOCIATION OF CYTOCHROME P450 2D6 (CYP2D6) POLYMORPHISMS WITH SUSCEPTIBILITY TO HEAD & NECK SQUAMOUS CELL CARCINOMA & TREATMENT RESPONSE
    Yadav, S. S. B.
    Pant, M. C.
    Parmar, D.
    ANNALS OF ONCOLOGY, 2014, 25
  • [46] Cytochrome P450 2D6 (CYP2D6) is decreased in patients with PPH: A potential mechanism for anorexigen-induced pulmonary hypertension
    Geraci, MW
    Cutrell, JD
    Moore, MD
    Tuder, RM
    Voelkel, NF
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A163 - A163
  • [47] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
    Crews, K. R.
    Gaedigk, A.
    Dunnenberger, H. M.
    Klein, T. E.
    Shen, D. D.
    Callaghan, J. T.
    Kharasch, E. D.
    Skaar, T. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (02) : 321 - 326
  • [48] Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro
    Liang, Bingqing
    Zhan, Yunyun
    Huang, Xiangxin
    Gu, Ermin
    Dai, Dapeng
    Cai, Jianping
    Hu, Guoxin
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 41 (06) : 759 - 765
  • [49] Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3,*4, and*6), and the metabolic capacity of CYP2D6 in Northern Iranian Population (Mazandaran)
    Shiran, Mohammad R.
    Soteh, Mohammad B. Hashemi
    Merat, Fatemeh
    Sarzare, Fatemeh
    Salehifar, Ebrahim
    DRUG METABOLISM REVIEWS, 2010, 42 : 260 - 261
  • [50] Intoxication with dextromethorphan in an adolescent with a genetic cytochrome P450 CYP2D6 deficiency
    Baumann, P
    Vlatkovic, D
    Macciardi, F
    THERAPIE, 1997, 52 (06): : 607 - 608
12345